London-based company OME Health has raised $1.25m in Seed funding to personalise healthcare.
Nordic technology investment firm Inventure led the round, which also gained participation from Doehler Group, Practica Capital, and a group of angel investors in the UK.
OME Health provides a personalised 12-week health plans based on a person’s gut microbiome, genetics, blood markers, and other health data.
Karolis Rosickas, the founder of OME Health, believes this is necessary as people become more health conscious: “Generic ‘eat vegetables 5-a-day’ and ‘exercise more’ type of recommendations were never truly effective and are no longer sufficient for people, who would like to understand their body better and make more effective health and wellness decisions.”
To create the personalised plans, an algorithm analyses human biology to help people achieve weight management, fitness, sleep, and mindfulness goals.
“The nutrition and health industry is at the stage where we can combine biological insights with wider health, activity, and physiological data to make lifestyle coaching plans truly personalised and engaging, which will drive sustainable health outcomes for our clients. OME Health is one of the few companies globally, which integrates a broad array of health data points to formulate a contextual understanding of our clients’ health and support them on their wellness journey,” Rosickas added.
Tech Chats: Energising the Enterprise Journey to 5G and IoT
OME Health was founded in 2016. Now that it has closed its Seed funding round, the company will focus its efforts on its commercial activities in the UK and Europe. OME Health currently partners with Bupa and food manufacturers to offer personalised nutrition plans.
Customers of OME Health can choose their goal before building a personalised plan.
The options are: to achieve a healthy weight, improve physical condition, optimise sleep and stress, and improve overall health.
The plans can also include chat-based coaching as well as a fitness plan and blood/microbe tests.